An electron microscopic study of clinical and laboratory-derived strains of teicoplanin-resistant Staphylococcus haemolyticus

被引:11
作者
Giovanetti, E [1 ]
Biavasco, F [1 ]
Pugnaloni, A [1 ]
Lupidi, R [1 ]
Biagini, G [1 ]
Varaldo, PE [1 ]
机构
[1] UNIV ANCONA,SCH MED,INST MORPHOL,I-60131 ANCONA,ITALY
来源
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE | 1996年 / 2卷 / 02期
关键词
D O I
10.1089/mdr.1996.2.239
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Staphylococcal resistance to glycopeptides (which involves more teicoplanin than vancomycin) is uncommon and largely confined to Staphylococcus haemolyticus, an emerging nosocomial pathogen with a tendency to develop antibiotic resistance, In this study, six S, haemolyticus strains, including two isogenic pairs of teicoplanin-susceptible/-resistant strains and two resistant clinical isolates, were used in a morphologic and morphometric electron microscope investigation, Cells from both clinical and laboratory-derived teicoplanin-resistant strains exhibited abnormally roughened, irregular outlines when observed by transmission electron microscopy, However, no significant differences in cell wall thickness resulted from morphometric analysis when the susceptible/resistant cells of the two isogenic pairs were compared, By scanning electron microscopy, an abnormally roughened, blistered surface was associated with teicoplanin-resistant cocci, A certain variability was noted between strains, not clearly related to the resistance level, In freeze-fracture investigations, a higher number per square micrometer of intramembrane particles, more significant in the E than in the P membrane fracture face, was observed in the laboratory-derived resistant clones as compared to susceptible parent strains, Further studies are needed to understand the cause-effect relation between these ultrastructural alterations and staphylococcal resistance to teicoplanin (but not to vancomycin).
引用
收藏
页码:239 / 243
页数:5
相关论文
共 21 条
[1]  
ARIOLI V, 1987, LANCET, V1, P39
[2]   GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
ARTHUR, M ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571
[3]   INVITRO ACTIVITIES OF 3 SEMISYNTHETIC AMIDE DERIVATIVES OF TEICOPLANIN, MDL-62208, MDL-62211, AND MDL-62873 [J].
BIAVASCO, F ;
LUPIDI, R ;
VARALDO, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) :331-338
[4]   DEVELOPMENT OF INVITRO RESISTANCE TO GLYCOPEPTIDE ANTIBIOTICS - ASSESSMENT IN STAPHYLOCOCCI OF DIFFERENT SPECIES [J].
BIAVASCO, F ;
GIOVANETTI, E ;
MONTANARI, MP ;
LUPIDI, R ;
VARALDO, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :71-79
[5]  
BIAVASCO F, 1994, 9 MED C CHEM JUN 12
[6]   RESISTANCE OF ENTEROCOCCI TO GLYCOPEPTIDES [J].
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2291-2296
[7]   CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS ISOLATES WITH DECREASED SUSCEPTIBILITY TO VANCOMYCIN AND TEICOPLANIN - ISOLATION AND PURIFICATION OF A CONSTITUTIVELY PRODUCED PROTEIN ASSOCIATED WITH DECREASED SUSCEPTIBILITY [J].
DAUM, RS ;
GUPTA, S ;
SABBAGH, R ;
MILEWSKI, WM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1066-1072
[8]   ANTIMICROBIAL RESISTANCE IN NOSOCOMIAL ISOLATES OF STAPHYLOCOCCUS-HAEMOLYTICUS [J].
FROGGATT, JW ;
JOHNSTON, JL ;
GALETTO, DW ;
ARCHER, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) :460-466
[9]   PERCENTAGES AND DISTRIBUTIONS OF TEICOPLANIN-RESISTANT AND VANCOMYCIN-RESISTANT STRAINS AMONG COAGULASE-NEGATIVE STAPHYLOCOCCI [J].
GOLDSTEIN, FW ;
COUTROT, A ;
SIEFFER, A ;
ACAR, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :899-900
[10]   INVITRO SELECTION OF RESISTANCE TO VANCOMYCIN IN BLOOD-STREAM ISOLATES OF STAPHYLOCOCCUS-HAEMOLYTICUS AND STAPHYLOCOCCUS-EPIDERMIDIS [J].
HERWALDT, L ;
BOYKEN, L ;
PFALLER, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (12) :1007-1012